Evaluation of appropriate use of bisphosphonates and denosumab in patients with cancer
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Oncology Pharmacy Practice"
DOI: 10.1177/1078155219842277
Abstract: Background National guidelines recommend screening and treatment for cancer-related bone disease and continued monitoring of bone-modifying agents. It is unclear whether a standardized screening tool is utilized to identify eligible patients and ensure appropriate supportive… read more here.
Keywords: hormone deprivation; bone modifying; cancer; therapy ... See more keywords